PacBio’s Compatible partner program recognizes third-party providers whose solutions have been evaluated to work seamlessly with PacBio instruments and data formats. As a named partner, Lucid Genomics ...
PACB stock gains on Lucid Genomics deal, boosting HiFi data analysis and simplifying workflows to speed insights and expand ...
PACB stock rises after unveiling a new FFPE workflow with Covaris, boosting HiFi sequencing accuracy and unlocking insights ...
The workflow leverages Covaris’ Adaptive Focused Acoustics ® (AFA)-based truXTRAC FFPE extraction method to recover longer DNA fragments, up to 5,000 base pairs, from FFPE tissues. PacBio’s Kinnex ...
(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...
PacBio has joined forces with Lucid Genomics to integrate its bioinformatics platform with PacBio’s HiFi sequencing, aiming to streamline genomic data analysis. Separately, investor Mary Minno ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
11don MSN
Pacific Biosciences (PACB) garnering attention amid involvement in Trillion Gene Atlas program
Pacific Biosciences of California Inc. (NASDAQ:PACB) is one of the 8 Best Life Sciences Penny Stocks to Buy. On March 18, ...
MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results